Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Sale and Maturity of Investments (2024 - 2026)

Updated

Vistagen Therapeutics' Sale and Maturity of Investments - Total was $6.68 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 233.8% from $2 million a year earlier and up 19.2% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Sale and Maturity of Investments (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vistagen Therapeutics' Sale and Maturity of Investments - Total was $23.85 million through Sep 30, 2026, up 44.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $21.58 million, up 79.4% from FY2025.

  • In earlier fiscal years, Sale and Maturity of Investments - Total was $12.03 million in FY2025.
  • The fiscal Q2 2027 figure marks the highest quarterly Sale and Maturity of Investments - Total since fiscal Q1 2026.
  • Compared with a year earlier, Sale and Maturity of Investments - Total was higher in three of the last five quarters, with growth averaging 72.7%.
  • Per Business Quant data, VTGN's Sale and Maturity of Investments - Total in the three fiscal quarters before Q2 2027 was $5.6 million (Q1 2027), $5.58 million (Q4 2026) and $6 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 308.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 405.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - 88.00 Mn
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 6.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.68 Mn
Jun 30, 2026 5.60 Mn
Mar 31, 2026 5.58 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 8.00 Mn
Mar 31, 2025 4.53 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 5.50 Mn
API Access

Vistagen Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VTGN&period=max&api_key=YOUR_API_KEY